Drug Shortage Report for TEVA-AMLODIPINE

Last updated on 2018-03-13 History
Report ID 9791
Drug Identification Number 02250497
Brand name TEVA-AMLODIPINE
Common or Proper name AMLODIPINE
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) AMLODIPINE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2017-05-04
Estimated end date 2018-01-30
Actual end date 2018-02-28
Shortage status Resolved
Updated date 2018-03-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-03-13 French Compare
v9 2018-03-13 English Compare
v8 2018-01-03 French Compare
v7 2018-01-03 English Compare
v6 2017-09-19 French Compare
v5 2017-09-19 English Compare
v4 2017-05-23 French Compare
v3 2017-05-23 English Compare
v2 2017-05-10 French Compare
v1 2017-05-10 English Compare

Showing 1 to 10 of 10